ArticleNeuro-oncology2024

Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.

Miguel Cosenza-Contreras et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.